2023
DOI: 10.1002/chem.202301845
|View full text |Cite
|
Sign up to set email alerts
|

Organotin(IV)‐Decorated Graphene Quantum Dots as Dual Platform for Molecular Imaging and Treatment of Triple Negative Breast Cancer

Abstract: The pharmacological activity of organotin(IV) complexes in cancer therapy is well recognized but their large applicability is hampered by their poor water solubility. Hence, carbon dots, in particular nitrogen‐doped graphene quantum dots (NGQDs), may be a promising alternative for the efficient delivery of organotin(IV) compounds as they have a substantial aqueous solubility, a good chemical stability, and non‐toxicity as well as a bright photoluminescence that make them ideal for theranostic applications agai… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 49 publications
0
4
0
Order By: Relevance
“…Organotin (IV)-decorated nitrogen-doped graphene quantum dots (NGQDs) were developed for targeting and treating triple-negative breast cancer. These NGQDs, noted for their water solubility, chemical stability, and photoluminescence, demonstrated high cytotoxic potential and successful cellular uptake, marking them as potential candidates for targeted therapy and molecular imaging in the context of aggressive breast cancer types [96].…”
Section: Quantum Dots For Targeted Drug Delivery In Breast Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…Organotin (IV)-decorated nitrogen-doped graphene quantum dots (NGQDs) were developed for targeting and treating triple-negative breast cancer. These NGQDs, noted for their water solubility, chemical stability, and photoluminescence, demonstrated high cytotoxic potential and successful cellular uptake, marking them as potential candidates for targeted therapy and molecular imaging in the context of aggressive breast cancer types [96].…”
Section: Quantum Dots For Targeted Drug Delivery In Breast Cancermentioning
confidence: 99%
“…Therapeutic Applications and Mechanisms: Exploring therapeutic applications involves evaluating drug delivery systems, therapeutic efficacy, and studying underlying mechanisms like apoptosis, and photothermal and photodynamic effects [1,3,6,7,10,16,17,25,96,115]. Mechanistic studies are critical as they delve into cellular responses, such as cell cycle progression and apoptosis, revealing how QDs influence biological processes at the molecular level [10,45,95,98,114,115].…”
Section: Testing and Evaluation Of The Qd Productsmentioning
confidence: 99%
“…6–8 Moreover, organotin compounds have demonstrated potential as cancer chemotherapeutic agents, attributed to their ability to induce apoptosis and their lipophilic nature. 9–17 This has prompted significant research efforts towards the design of organotin( iv ) complexes as potential anticancer agents, aiming to enhance their therapeutic efficacy through selective cytotoxicity against cancer cells. 11–18…”
Section: Introductionmentioning
confidence: 99%
“…9–17 This has prompted significant research efforts towards the design of organotin( iv ) complexes as potential anticancer agents, aiming to enhance their therapeutic efficacy through selective cytotoxicity against cancer cells. 11–18…”
Section: Introductionmentioning
confidence: 99%